图片来源:摄图网
近日,港股上市公司德琪医药发布公告称,与翰森制药达成独家合作协议,由翰森制药负责塞利尼索在中国大陆的商业化, 德琪医药将获最高2亿元首付款及最高5.35亿元里程碑付款。
据了解,塞利尼索是德琪医药首个上市商业化产品,从Karyopharm引进,...查看全文
$Karyopharm Therapeutics(KPTI)$ 8-K - Current report Filed: 2016-08-04 AccNo: 0001193125-16-670970 Size: 109 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Karyopharm Therapeutics(KPTI)$ 美东时间 2016-08-04 09:00 Before Open:KARYOPHARM THER Earning Release . Wall St EPS Est ($):-0.76. 网页链接
$Karyopharm Therapeutics(KPTI)$ 8-K - Current report Filed: 2016-06-17 AccNo: 0001193125-16-624961 Size: 19 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Karyopharm Therapeutics(KPTI)$ 内部交易: 2016-06-23,10% Owner,Chione Ltd ,卖出,18824普通股, $8.03
$Karyopharm Therapeutics(KPTI)$ CORRESP [Cover] - Correspondence Filed: 2016-05-02 AccNo: 0001193125-16-572593 Size: 7 KB 网页链接
$Karyopharm Therapeutics(KPTI)$ 美东时间 2016-06-22 14:00 Karyopharm Therapeutics Inc at JMP Securities Life Sciences Conference 网页链接
$Karyopharm Therapeutics(KPTI)$ 美东时间 2016-06-08 15:00 Karyopharm Therapeutics Inc at Jefferies Healthcare Conference 网页链接
$Karyopharm Therapeutics(KPTI)$ 内部交易: 2016-06-02,10% Owner,Chione Ltd ,卖出,17855普通股, $9.65
$Karyopharm Therapeutics(KPTI)$ 内部交易: 2016-06-01,10% Owner,Chione Ltd ,卖出,17568普通股, $9.64
$Karyopharm Therapeutics(KPTI)$ 内部交易: 2016-05-31,10% Owner,Chione Ltd ,卖出,17096普通股, $9.66